13 results
8-K
EX-99.1
STRO
Sutro Biopharma Inc
13 Nov 23
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
– including ADCs, iADCs, and ADC2. The diversity of product candidate attributes enabled by Sutro technology is what originally attracted me
PRE 14A
STRO
Sutro Biopharma Inc
14 Apr 23
Preliminary proxy
4:05pm
candidates, including such factors as business experience, diversity and personal skills in life sciences and biotechnology, finance, marketing … for nomination for reelection, the Nominating and Governance Committee considers director tenure. We value diversity on a company-wide basis but have not yet
DEF 14A
d44998x7qwsa
26 Apr 19
Definitive proxy
12:00am
DRSLTR
7li8xrx3jk68s 9us
8 Aug 18
Correspondence regarding draft registration statement
12:00am
- Prev
- 1
- Next